By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aclaris Therapeutics 

101 Lindenwood Drive
Suite 400
Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-324-7933 Fax: 484-324-7949


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aclaris (ACRS) To Present At The Morgan Stanley 2016 Healthcare Conference 9/6/2016 10:39:32 AM
Aclaris (ACRS) Announces Positive Results In Phase II Clinical Trial Of A-101 For Treatment Of Common Warts 8/18/2016 8:03:11 AM
Aclaris (ACRS) Reports Second Quarter 2016 Financial Results 8/11/2016 11:23:01 AM
Aclaris (ACRS) Announces Appointment Of Bill Humphries To Board Of Directors 8/5/2016 10:36:44 AM
Aclaris (ACRS) To Announce Second Quarter 2016 Financial Results On August 11, 2016 8/2/2016 8:19:28 AM
Aclaris (ACRS) To Ring The Nasdaq Stock Market Closing Bell 7/25/2016 8:54:42 AM
Aclaris (ACRS) Completes Enrollment Of Phase 3 Pivotal Trials Of A-101 For The Treatment Of Seborrheic Keratosis (SK); Provides Update On Clinical Programs 7/25/2016 8:53:45 AM
Aclaris (ACRS) Appoints Kevin Scott As Vice President Of Sales 5/5/2016 8:09:10 AM
Aclaris (ACRS) Initiates Phase II Clinical Trial Of A-101 For Treatment Of Common Warts 12/7/2015 7:43:30 AM
Aclaris (ACRS) Reports Third Quarter 2015 Financial Results 11/19/2015 8:12:02 AM
123
//-->